1 Product identity
Ingredient risk
1 ingredient to use with caution
Benfotiamine
BrandXYMOGEN→Vitamin Capsule 7 ingredients 1 caution DSLD #5945Net contents: 30 Vegetable Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-02-23
2 Ingredients (7)
IngredientGroupSafety
BenfotiamineBenfotiamine—
Microcrystalline CelluloseCellulose—
HPMCHypromellose—
Stearic AcidStearic Acid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID5945
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-02-23
6 More from XYMOGEN
View XYMOGEN Safety Scorecard → 108 products
5-HTP5-MTHF Plus B12 Natural Cherry FlavorActivNutrientsActivNutrients Chewable Natural Mixed Berry FlavorALAmax ProtectAngiNOX Elite Natural Fruit Punch Flavor7 Cite this page
Vancouver
Pkhakadze G. Benfotiamine — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 17]. Available from: https://supplement.ge/products/benfotiamine-5945/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG